Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	558.45B
Revenue (ttm)	810.68B
Net Income (ttm)	26.03B
Shares Out	12.18M
EPS (ttm)	2,134.05
PE Ratio	21.48
Forward PE	n/a
Dividend	525.00 (1.15%)
Ex-Dividend Date	Mar 28, 2025

Volume	22,270
Average Volume	38,916
Open	47,000
Previous Close	47,100
Day's Range	45,850 - 47,200
52-Week Range	20,500 - 54,900
Beta	1.01
RSI	46.41
Earnings Date	Aug 1, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.